172 related articles for article (PubMed ID: 2882618)
1. Disorders in the system of cyclic nucleotides in atherosclerosis: cyclic AMP and cyclic GMP content and activity of related enzymes in human aorta.
Tertov VV; Orekhov AN; Grigorian GYu ; Kurennaya GS; Kudryashov SA; Tkachuk VA; Smirnov VN
Tissue Cell; 1987; 19(1):21-8. PubMed ID: 2882618
[TBL] [Abstract][Full Text] [Related]
2. [The content of cyclic nucleotides in an organ culture of normal and atherosclerosis-affected human aorta].
Tertov VV; Tabagari SI; Orekhov AN
Biull Eksp Biol Med; 1989 May; 107(5):575-7. PubMed ID: 2544234
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP and cyclic GMP content in a short-term organ culture of normal and atherosclerotic human aorta.
Tertov VV; Orekhov AN; Smirnov VN
Artery; 1986; 13(6):373-82. PubMed ID: 3022690
[TBL] [Abstract][Full Text] [Related]
4. On the role of cyclic nucleotides in the pathogenesis of human atherosclerosis.
Tertov VV; Orekhov AN; Smirnov VN
Biomed Biochim Acta; 1987; 46(10):727-33. PubMed ID: 2451514
[TBL] [Abstract][Full Text] [Related]
5. Cyclic nucleotides and atherosclerosis: studies in primary culture of human aortic cells.
Tertov VV; Orekhov AN; Kudryashov SA; Klibanov AL; Ivanov NN; Torchilin VP; Smirnov VN
Exp Mol Pathol; 1987 Dec; 47(3):377-89. PubMed ID: 2445600
[TBL] [Abstract][Full Text] [Related]
6. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
Yu SM; Kuo SC
Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
[TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
Barber AJ
Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
[TBL] [Abstract][Full Text] [Related]
8. Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.
; ; . PubMed ID: 2894877
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
